Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer

Clinical trial NCT00984282 · COMPLETED

Trial details

NCT number: NCT00984282
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Thyroid Neoplasms

Start date: 2009-10-15
Primary completion: 2012-08-31
Enrollment: 417

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.